Remove 2015 Remove Medicaid Remove Medicare
article thumbnail

Abstract WMP106: The Impact of Social Determinants of Health on Ambulatory Status at Discharge Following Acute Ischemic Stroke: Findings From the Get With the Guidelines-Stroke Registry

Stroke Journal

The objective of our analysis was to determine if SDOH are associated with ambulatory status at discharge following acute ischemic stroke(IS) hospitalization.Methods:We included IS patients hospitalized from January 1, 2015-December 31, 2019 who were ambulating at baseline and had known county of residence in the GWTG registry.

Stroke 40
article thumbnail

How Interoperability Can Streamline the MIPS Reporting Changes

GEMMS

Established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) , the MIPS Program is pivotal in determining Medicare payment adjustments for healthcare practices. What is MIPS?

article thumbnail

Changes to MIPS 2024: What Cardiology Clinics Need to Know, Including Quality Payment Program

GEMMS

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). The 2024 payment adjustment is important to compensation for Medicaid services provided. EHR technology certified to the 2015 Cures Update must be in place by October 3, 2023.

article thumbnail

Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation

Circulation: Cardiovascular Quality & Outcomes

In 2020, patients had higher odds of initiating LAAO use than in 2015 (0.52 0.68]) versus White race, and Medicaid eligibility (aOR, 0.61 [95% CI, 0.58–0.64]) versus 9.32%; adjusted odds ratio [aOR], 13.64 [95% CI, 12.56–14.81]). Old age (ie, >85 versus 65–75 years; aOR, 0.84 [95% CI, 0.80–0.88]),

article thumbnail

Abstract 129: Endovascular Therapy in Cerebral Venous Thrombosis: Nationwide Insights and Implications for Mortality

Stroke: Vascular and Interventional Neurology

We examined the demographic and clinical correlates of EVT use in CVT and assessed its impact on patient outcomes utilizing a national database.MethodsWe identified CVT cases from 2015 to 2020 in the National Inpatient Sample, with EVT as the primary exposure. Individuals with Medicare (OR: 0.39, 95% CI: 0.26‐0.59, p<0.001).ConclusionWe